Bilibili IncUnveiled new $300 million share repurchase program.
Absci shares surged 24% in premarket trading after the biotechnology company reported positive interim Phase 1 safety data for its hair-loss antibody treatment ABS-201, while FuelCell Energy jumped 16% on a strategic agreement to supply up to 380 megawatts of clean power for data centers. Cerebras Systems tumbled about 14% after forecasting 2026 adjusted gross margins of 38% to 41%, below the 47% margin reported in the first quarter, in its first earnings report since its IPO. FedEx fell 7.3% after issuing a fiscal 2027 earnings outlook that missed Wall Street expectations, despite reporting fourth-quarter earnings and revenue above estimates. Bilibili rose 2.4% after unveiling a new $300 million share repurchase program that will remain in place for 24 months.
Bilibili IncUnveiled new $300 million share repurchase program.
Absci CorpPositive interim Phase 1 safety data for hair-loss antibody treatment ABS-201.
Cerebras Systems Inc. Class A Common StockForecasted 2026 adjusted gross margins of 38%-41%, below Q1's 47%.
FuelCell Energy IncStrategic agreement to supply up to 380 MW of clean power for data centers.
FedEx CorporationFiscal 2027 earnings outlook missed Wall Street expectations.
Micron Technology Inc